BSE filing, NSE: GAUDIUMIVF. Summary written from the filing by ALFA Finder's alert engine.
Gaudium IVF And Women Health Ltd: key numbers
- Share price
- ₹107.60
- Market cap
- ₹783.2 Cr
- Revenue (annual)
- ₹104.4 Cr
- Net profit (annual)
- ₹24.46 Cr
- P/E (TTM)
- 33.8×Sector 47.0×
- Promoter holding
- 71.29%+0.00% QoQ
- FII holding
- 1.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Gaudium IVF And Women Health Ltd
All →Gaudium IVF And Women Health Results Update
Gaudium IVF reported Q2 FY27 revenue of ₹37.4 crore, up 17.9% YoY, with H1 revenue at ₹56.8 crore. Two new IVF hubs commenced operations during the quarter.
Gaudium IVF And Women Health Q2 FY27 Results: Net Profit ₹9.4 Cr, Up 0.0% YoY
Gaudium IVF And Women Health Ltd reported revenue from operations of ₹37.4 Cr (+18.0% YoY) and net profit of ₹9.4 Cr (+0.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹9.4 Cr · +0.0% YoY
Gaudium IVF And Women Health Board Meeting Date
GAUDIUM IVF AND WOMEN HEALTH LIMITED intimated a board meeting on 12 Nov 2026 to consider unaudited standalone and consolidated half-yearly results for the period ended September 2026. No financial figures are disclosed in this intimation.
Gaudium IVF And Women Health Other Announcement
Gaudium IVF and Women Health Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Gaudium IVF And Women Health Annual General Meeting
Gaudium IVF conducted its 11th Annual General Meeting on September 28, 2026, via video conferencing, transacting all businesses specified in the AGM notice.
Gaudium IVF And Women Health Capacity Expansion
Gaudium IVF and Women Health Limited commenced operations at its new IVF Centre/Hub in Gurgaon, Haryana, effective September 24, 2026.
- new IVF center
- 1.0 centers
Other management change announcements
All →Ruby Mills Management Change
Ruby Mills appointed two directors and a COO, with Rishabh Shah ceasing as President. Changes take effect from 12 to 23 November 2026.
Afcom Holdings Management Change
Afcom Holdings' non-executive director Jaganmohan Manthena resigned effective November 12, 2026, along with all committee roles. The resignation letter citing personal and entrepreneurial priorities is enclosed.
Mehai Technology Management Change
MEHAI Technology's Company Secretary, Mr. Sandipan Lai, resigned for personal reasons, effective November 12, 2026. The change was approved at a board meeting held the same day.
Prakash Pipes Management Change
Prakash Pipes appointed Sachin Ghanghas as Company Secretary, Amitava Ray as Executive Director and Priyanka Agarwal as Independent Director, effective December 1, 2026 for the directors. These are board and KMP appointments with no monetary value.
Kwality Pharmaceuticals Management Change
Kwality Pharmaceuticals disclosed the resignation of statutory auditor M/s. Vijay Mehra & Co., citing pre-occupation in other assignments. B S R & Co. LLP is proposed as the replacement auditor until the 46th AGM.
PTC Industries Management Change
PTC Industries' Non-Executive Independent Director, Rakesh Shukla, resigned effective November 12, 2026, citing personal commitments. The company disclosed the resignation and the letter under Regulation 30.